Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Aid, assessment, carryback, combat, deferment, depreciation, disruption, duration, Economic, employer, experienced, foregoing, global, goal, government, Health, implemented, improve, improvement, law, licensor, liquidity, monitoring, movement, October, onMarch, Organization, outbreak, pandemic, payroll, people, Prescription, property, provision, qualified, reduction, refundable, Relief, response, simplify, Simplifying, social, spread, submission, tax, technical, temporary, timeline, uncertainty, User, world, worldwide
Removed:
advance, advice, advisory, assistance, calendar, collectively, communication, Concurrently, conducting, consisting, contractually, delivery, derived, designated, earlier, education, equal, execution, exempt, fiduciary, Gansevoort, granted, increase, investor, irrevocably, liable, limitation, marketing, matured, medical, MSA, Nonemployee, obligated, offered, planning, receive, relation, rendered, spending, Street, termination, Updated, utilize, waived, waiver
Filing tables
Filing exhibits
Related press release
ATXI similar filings
Filing view
External links
Exhibit 32.1
Certification of
Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Lucy Lu, M.D., Chief Executive Officer of Avenue Therapeutics, Inc. (the “Company”), in compliance with Section 906 of the Sarbanes-Oxley Act of 2002, hereby certify that, to the best of my knowledge, the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2020 (the “Report”) filed with the Securities and Exchange Commission:
• | Fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
• | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Lucy Lu, M.D. | ||
Lucy Lu, M.D. | ||
President, Chief Executive Officer and Director | ||
(Principal Executive Officer) | ||
May 11, 2020 |